- call +1-201-465-4211
- email sales@mrinsights.biz
Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers are used to increase the growth of red blood cells in the body by stimulating the bone marrow.
Scope of the Report:
Major factors contributing to the growth of the global EPO biomarkers market include increasing sedentary lifestyle and faulty dietary habits has increased the prevalence of cancers and chronic kidney diseases in the emerged economies. Moreover, the increasing incidence of end-stage renal disorders and hematological diseases is further increasing the demand for EPO biomarkers.
The global EPO Biomarkers market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of EPO Biomarkers.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the EPO Biomarkers market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the EPO Biomarkers market by product type and applications/end industries.
Market Segment by Companies, this report covers
Siemens
Thermo Fisher Scientific
Pfizer
Novartis
Johnson & Johnson
Merck
LG Life Sciences India
Amgen
Roche
Agilent
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Erythropoietin alfa
Erythropoietin beta
Erythropoietin zeta
Erythropoietin theta
Recombinant human erythropoietin
Darbepoietin alfa
Market Segment by Applications, can be divided into
Diagnostic centers
Ambulatory care and surgical centers
Hospitals
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 EPO Biomarkers Market Overview
1.1 Product Overview and Scope of EPO Biomarkers
1.2 Classification of EPO Biomarkers by Types
1.2.1 Global EPO Biomarkers Revenue Comparison by Types (2017-2023)
1.2.2 Global EPO Biomarkers Revenue Market Share by Types in 2017
1.2.3 Erythropoietin alfa
1.2.4 Erythropoietin beta
1.2.5 Erythropoietin zeta
1.2.6 Erythropoietin theta
1.2.7 Recombinant human erythropoietin
1.2.8 Darbepoietin alfa
1.3 Global EPO Biomarkers Market by Application
1.3.1 Global EPO Biomarkers Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Diagnostic centers
1.3.3 Ambulatory care and surgical centers
1.3.4 Hospitals
1.4 Global EPO Biomarkers Market by Regions
1.4.1 Global EPO Biomarkers Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) EPO Biomarkers Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) EPO Biomarkers Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) EPO Biomarkers Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) EPO Biomarkers Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) EPO Biomarkers Status and Prospect (2013-2023)
1.5 Global Market Size of EPO Biomarkers (2013-2023)
2 Manufacturers Profiles
2.1 Siemens
2.1.1 Business Overview
2.1.2 EPO Biomarkers Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Siemens EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.2 Thermo Fisher Scientific
2.2.1 Business Overview
2.2.2 EPO Biomarkers Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Thermo Fisher Scientific EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 EPO Biomarkers Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 EPO Biomarkers Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 EPO Biomarkers Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
2.6.1 Business Overview
2.6.2 EPO Biomarkers Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.7 LG Life Sciences India
2.7.1 Business Overview
2.7.2 EPO Biomarkers Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 LG Life Sciences India EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.8 Amgen
2.8.1 Business Overview
2.8.2 EPO Biomarkers Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Amgen EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.9 Roche
2.9.1 Business Overview
2.9.2 EPO Biomarkers Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Roche EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
2.10 Agilent
2.10.1 Business Overview
2.10.2 EPO Biomarkers Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Agilent EPO Biomarkers Revenue, Gross Margin and Market Share (2016-2017)
3 Global EPO Biomarkers Market Competition, by Players
3.1 Global EPO Biomarkers Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 EPO Biomarkers Players Market Share
3.2.2 Top 10 EPO Biomarkers Players Market Share
3.3 Market Competition Trend
4 Global EPO Biomarkers Market Size by Regions
4.1 Global EPO Biomarkers Revenue and Market Share by Regions
4.2 North America EPO Biomarkers Revenue and Growth Rate (2013-2018)
4.3 Europe EPO Biomarkers Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific EPO Biomarkers Revenue and Growth Rate (2013-2018)
4.5 South America EPO Biomarkers Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa EPO Biomarkers Revenue and Growth Rate (2013-2018)
5 North America EPO Biomarkers Revenue by Countries
5.1 North America EPO Biomarkers Revenue by Countries (2013-2018)
5.2 USA EPO Biomarkers Revenue and Growth Rate (2013-2018)
5.3 Canada EPO Biomarkers Revenue and Growth Rate (2013-2018)
5.4 Mexico EPO Biomarkers Revenue and Growth Rate (2013-2018)
6 Europe EPO Biomarkers Revenue by Countries
6.1 Europe EPO Biomarkers Revenue by Countries (2013-2018)
6.2 Germany EPO Biomarkers Revenue and Growth Rate (2013-2018)
6.3 UK EPO Biomarkers Revenue and Growth Rate (2013-2018)
6.4 France EPO Biomarkers Revenue and Growth Rate (2013-2018)
6.5 Russia EPO Biomarkers Revenue and Growth Rate (2013-2018)
6.6 Italy EPO Biomarkers Revenue and Growth Rate (2013-2018)
7 Asia-Pacific EPO Biomarkers Revenue by Countries
7.1 Asia-Pacific EPO Biomarkers Revenue by Countries (2013-2018)
7.2 China EPO Biomarkers Revenue and Growth Rate (2013-2018)
7.3 Japan EPO Biomarkers Revenue and Growth Rate (2013-2018)
7.4 Korea EPO Biomarkers Revenue and Growth Rate (2013-2018)
7.5 India EPO Biomarkers Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia EPO Biomarkers Revenue and Growth Rate (2013-2018)
8 South America EPO Biomarkers Revenue by Countries
8.1 South America EPO Biomarkers Revenue by Countries (2013-2018)
8.2 Brazil EPO Biomarkers Revenue and Growth Rate (2013-2018)
8.3 Argentina EPO Biomarkers Revenue and Growth Rate (2013-2018)
8.4 Colombia EPO Biomarkers Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue EPO Biomarkers by Countries
9.1 Middle East and Africa EPO Biomarkers Revenue by Countries (2013-2018)
9.2 Saudi Arabia EPO Biomarkers Revenue and Growth Rate (2013-2018)
9.3 UAE EPO Biomarkers Revenue and Growth Rate (2013-2018)
9.4 Egypt EPO Biomarkers Revenue and Growth Rate (2013-2018)
9.5 Nigeria EPO Biomarkers Revenue and Growth Rate (2013-2018)
9.6 South Africa EPO Biomarkers Revenue and Growth Rate (2013-2018)
10 Global EPO Biomarkers Market Segment by Type
10.1 Global EPO Biomarkers Revenue and Market Share by Type (2013-2018)
10.2 Global EPO Biomarkers Market Forecast by Type (2018-2023)
10.3 Erythropoietin alfa Revenue Growth Rate (2013-2023)
10.4 Erythropoietin beta Revenue Growth Rate (2013-2023)
10.5 Erythropoietin zeta Revenue Growth Rate (2013-2023)
10.6 Erythropoietin theta Revenue Growth Rate (2013-2023)
10.7 Recombinant human erythropoietin Revenue Growth Rate (2013-2023)
10.8 Darbepoietin alfa Revenue Growth Rate (2013-2023)
11 Global EPO Biomarkers Market Segment by Application
11.1 Global EPO Biomarkers Revenue Market Share by Application (2013-2018)
11.2 EPO Biomarkers Market Forecast by Application (2018-2023)
11.3 Diagnostic centers Revenue Growth (2013-2018)
11.4 Ambulatory care and surgical centers Revenue Growth (2013-2018)
11.5 Hospitals Revenue Growth (2013-2018)
12 Global EPO Biomarkers Market Size Forecast (2018-2023)
12.1 Global EPO Biomarkers Market Size Forecast (2018-2023)
12.2 Global EPO Biomarkers Market Forecast by Regions (2018-2023)
12.3 North America EPO Biomarkers Revenue Market Forecast (2018-2023)
12.4 Europe EPO Biomarkers Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific EPO Biomarkers Revenue Market Forecast (2018-2023)
12.6 South America EPO Biomarkers Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa EPO Biomarkers Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure EPO Biomarkers Picture
Table Product Specifications of EPO Biomarkers
Table Global EPO Biomarkers and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
